tES Modalities for the Treatment of ADHD (NCT06974136) | Clinical Trial Compass
CompletedNot Applicable
tES Modalities for the Treatment of ADHD
Iran45 participantsStarted 2025-03-30
Plain-language summary
This project investigates the efficacy of transcranial electrical stimulation (tES) modalities, specifically transcranial direct current stimulation (tDCS) and transcranial alternating current stimulation (tACS), for treating Attention-Deficit/Hyperactivity Disorder (ADHD) in children and adolescents.
Who can participate
Age range
7 Years – 18 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Diagnosis of ADHD by a licensed psychiatrist and a behavioral checklist
* being 7-18 years old
* providing written informed consent signed by parents
Exclusion Criteria:
* comorbidity with other neurodevelopmental disorders
* Comorbidity with other neurological disorders
* previous history of neurosurgery
* Presence of any ferromagnetic metal in the head
* implanted medical devices in the head or neck region
* history of non-controlled epilepsy with seizures in the last year
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1This trial used transcranial electrical stimulation (tES) instead of medication to target ADHD symptoms — can you explain how that approach works and whether it's something worth considering for my situation?
2Since this trial has already completed and measured ADHD symptoms using a clinical rating scale, have the results been published yet, and do they show any meaningful changes that might be relevant to my care?
3The trial is listed as Phase NA, which often applies to device or non-drug studies — what does that mean for how much we know about the safety of tES compared to established ADHD treatments I might already be eligible for?
4Given that this trial is already completed and no longer enrolling, are there any similar or follow-up studies using transcranial electrical stimulation for ADHD that I could potentially look into with your guidance?
5How does tES compare to the standard medication or behavioral therapy options you'd normally recommend for ADHD, especially if the trial results suggest it had some effect on symptom rating scales?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
ADHD symptoms- Clinical rating scale
Timeframe: Baseline, week 2, up to 1 month after the intervention
Trial details
NCT IDNCT06974136
SponsorThe National Brain Mapping Laboratory (NBML)